The two patients who died were cared for by one of the authors (PRC) who telephoned the parents personally to ensure their willingness to participate. One patient died in Stage 2 and one in Stage 3. The data from these two families were very similar to the rest of the sample, and are, therefore, not presented separately. STUDY DESIGN Participants were mailed a description of each stage. Seventeen parents completed the Impact of Child Neurologic Disability Scale (ICND) questionnaires for each stage that their child had experienced. The ICND is a validated 44-item questionnaire assessing the impact of epilepsy on children and families in four domains: epilepsy, cognition, behavior, and physical/neurological function (Camfield et al. 2003) .
Twenty-four parents completed a semi-structured interview with one of the authors (KN), three in person and 21 by telephone. Participants described their child's illness, personal experiences, perceptions of their child's healthcare, and coping mechanisms or support, both effective and lacking. For each stage parents were asked to report spontaneously events or experiences that were particularly positive or negative in caring for their child and positive and negative experiences with the healthcare system.The total numbers reported were summed. Most interviews were with mothers only but all four interviews with both parents showed similar responses, so they were counted as one participant.
STATISTICAL ANALYSIS
Data were analyzed using SPSS (version 12.0). χ 2 or Fisher's exact test were used for non-parametric comparisons, t-tests for continuous variables, and paired t-tests for the ICND data. Significance was set at p<0.05.
Results

CASE STUDY
This female presented with febrile status epilepticus at 3 1 ⁄ 2 months. By age 1 year she had experienced more than 10 episodes of status lasting up to 1 1 ⁄ 2 hours but development was normal. Her mother recalls this time as very difficult because of frightening seizures and diagnostic uncertainty. At 11 months additional seizure types emerged which were resistant to 15 different medications. Minor temperature elevations precipitated seizures. Cognitive development plateaued with severe hyperactivity and self-injurious behavior. For outings, she was only manageable if constrained in a wheelchair, equipped with oxygen, cell phone, a rectal diazepam kit, and a suction machine. An indwelling venous access device was inserted for prompt treatment and a personalized status epilepticus protocol was established in the hospital emergency department. At age 14 years she has severe mental retardation* and has lost the ability to walk. She has fewer seizures but still has occasional episodes of status epilepticus. Magnetic resonance imaging and EEG show no diagnostic change.
She has had 471 emergency room visits and been hospitalized 25 times. A mutation in SCN1A was identified. Her parents separated when she was 12 years old. For years, neighbors were constantly 'on-call' to care for her sibling when she was rushed to the hospital. The family never left the city, always remaining within 20 minutes' drive from the hospital. Ambulance attendants have become their friends and a nurse assistant provides respite care, but other family members offer little assistance.
Her mother eventually set aside her original expectations for her child and can enjoy her as a whole person. She identified the school and an early intervention program as helpful. A short walk each day on her own is critical but she does not venture more than 15 minutes from home because she must always be available.
This case typifies the clinical course of most of our cases entering Stage 3. Milder cases in Stage 3 have been noted (Dravet et al. 2002) .
DEMOGRAPHICS
Descriptive statistics of parents and children are outlined in Tables I and II . There was no significant difference between the three participant groups or between geographical locations. problems and developmental delay were not significant concerns. This was confirmed by the ICND, where parents reported in Stage 1 that epilepsy had a significantly greater impact on their child's life than behavior (p=0.007), cognition (p<0.001), or physical/neurological limitations (p<0.001).
Parents identified the stage(s) that stood out as particularly difficult. Sixteen reported Stage 1 to be very difficult, significantly more than other stages (p=0.03). Of those 16 parents, 13 identified the uncertainty before diagnosis as very stressful. Of other causes of stress identified by the 16 parents, four cited fear during prolonged seizures, two cited time in hospital, and two cited waiting for a seizure during a febrile illness. All parents reported an average of 1.25 very negative events in this stage and 13 reported no positive experiences in caring for their child during Stage 1.
Parents reported a mean of 0.88 (range 0-2) positive experiences with the healthcare system, the lowest of all the stages. A mean of 0.88 (range 0-3) negative experiences were noted, often related to healthcare staff who parents were meeting for the first time.
Eleven parents found other caregivers in Stage 1, mostly babysitters who did not provide overnight relief, while 13 parents reported no other caregivers.
As described below, most parents reported no alterations in their relationships with others in Stage 1. Fourteen reported no change in relationships with friends, while one parent reported a positive impact. Sixteen noted no change in extended or nuclear family relationships, five reported a positive impact, and only two described a negative impact, including strain, loss of connections, or loss of relationship. Change in spousal relationships was more frequent. Eight parents reported no change, seven noted positive impact, and nine reported negative impact.
STAGE 2
Stage 2 was characterized by the development of other seizure types plus developmental and behavioral problems (Table III) . Ten children were in Stage 2 at the time of interview. Retrospective experiences of Stage 2 by parents of children in Stage 3 were included in the analysis.
Medication efficacy was rated slightly better than in Stage 1 (mean 4.1/10 [SD 2.6]; ns). Seizures remained the greatest source of stress and difficulty for parents, which was confirmed by the ICND. While the negative effects of behavior, cognition, and physical or neurological limitations were significantly greater than in Stage 1 (p<0.001), epilepsy continued to have a significantly greater effect on the child's life than the other three domains (p<0.01).
Thirteen parents described Stage 2 as being particularly difficult. Parents of children in Stages 2 and 3 did not differ in their description of difficult stages (p=1.00). Of those 13 parents, 10 described periods of increased seizure frequency as especially difficult. Of other causes of stress in Stage 2 identified by the 13 parents, six cited realization of developmental delay, three cited behavioral problems, and four cited loss of original hopes for their child's future.
All parents reported more positive experiences during this stage. Nineteen identified at least one positive experience in caring for their child in Stage 2. Parents reported a mean of 2.13 negative experiences in Stage 2, significantly higher than Stage 1 (p=0.01). While parents in Stage 1 focused on seizures as the primary negative event, parents in Stage 2 reported negative experiences with seizures, developmental delay, behavior, and loss of original hopes for their child.
On average, 2.08 (range 0-6) positive experiences with the healthcare system and 0.88 (range 0-2) negative experiences were reported. Positive experiences were increased from Stage 1 (p<0.001).
Of all families currently in Stage 2 or 3, 18 had access to one caregiver during Stage 2. Of those presently in Stage 2, seven of 10 reported respite care by a family member, while five used a trained professional. Seven parents reported they had trouble finding a caregiver; potential caregivers were frightened by seizures. One family could not find a caregiver at all at this stage.
Parents' relationships with others became significantly affected by Stage 2. Nine reported negative effects on relationships with family (p<0.001 compared with Stage 1), 15 with friends (p=0.02), and 13 with their spouse (p<0.001).
Every parent in Stage 2 identified effective coping mechanisms, with family and support groups cited most commonly (each reported by four). Coping mechanisms were divided into personal/internal (including religious faith, activities outside the home without their child, and personal research about Dravet syndrome) and external supports (including friends, family, and support groups). Five reported more external coping mechanisms than internal while four used both equally. Only one parent relied more on personal/internal coping mechanisms than external during this stage.
Sleep problems became a major issue. Twenty-two parents reported sleep problems and of those, 12 reported that they were worst in Stage 2. Of the 22 parents reporting sleep problems, 16 cited night time seizures, 16 cited trouble falling asleep, and 14 cited trouble staying asleep. Ten parents had tried conventional or herbal medication for their child's sleep difficulties, and six believed they were helpful. abilities and increasing behavioral problems (Table III) . Medication efficacy was better than in other stages (6.9/10 [SD 1.4], p<0.001). ICND data confirmed that cognitive, behavioral, and physical or neurological limitations remained constant, but the effect of epilepsy on the child's life was less than in Stage 2 (p=0.028). Fourteen children were in Stage 3. Two parents described Stage 3 as being very difficult. The most commonly identified issue was caring for a physically large child. Two children in Stage 3 were living in group homes.
Parents reported fewer negative experiences in Stage 3 (mean 0.64, range 0-3) and positive experiences were the highest of all the stages (mean 1.57, range 0-4; compared with Stage 1, p=0.012 and with Stage 2, p=0.026 ). The most common positive experience, reported by 11 parents, was increased freedom and decreased anxiety with fewer seizures. Only one parent reported worsening sleep difficulties during Stage 3.
Parents reported fewer positive experiences with the healthcare system (mean 1.93, range 1-5). Only one parent noted one negative experience in Stage 3.
Thirteen parents of children in Stage 3 used ≥1 respite care provider. Eight reported care by a family member and 10 by a trained professional. Ten parents in this stage reported major difficulty in finding a caregiver. Of the barriers identified, three parents reported fear of seizures, two parents cited trust of a caregiver, and two reported trouble finding qualified help.
Parents reported further declines in relationships with friends, with 11 noting a negative impact during Stage 3. Negative impact on relationships with family and spouse remained fairly constant from Stage 2.
Coping mechanisms varied widely, but the most common included family activities outside the home (cited by six parents), friends (cited by four), and religious faith (also cited by four). Parents of children in Stage 3 tended to rely more on personal/internal supports than parents of children in Stage 2 (ns). Five parents reported more internal coping mechanisms than external, five used both equally, and four relied more on external coping mechanisms.
EFFECT ON SIBLINGS Twenty-one parents had one other child and 15 identified both positive and negative impacts on siblings. The most common positive effect was a caring nature and interest in helping others, reported by 16. Negative effects were more varied, but most common were decreased attention and resentment of the affected sibling.
PARENTAL RECOMMENDATIONS
Of parents' most common suggestion for healthcare professionals, 15 wanted them to listen carefully to their experiences and suggestions, 13 suggested that healthcare professionals should learn more about Dravet syndrome to better educate families, and eight highlighted the importance of providing a list of helpful community resources.
Seventeen stressed the importance for parents of a newlydiagnosed child to educate themselves about Dravet syndrome, 11 recommended talking to other affected families, and 11 suggested asking many questions of healthcare providers and other parents.
When asked about the adequacy of resources and support mechanisms, 15 parents noted a lack of respite care and 15 reported inadequate information about Dravet syndrome. Lack of family support was discussed by 12 parents, nine reported lack of support from friends, seven reported inadequate financial support, and seven noted insufficient school assistance.
Discussion
This study has three main findings that lead to recommendations for care. First, most children with Dravet syndrome pass through three distinct stages, each with specific challenges. Stage 1 is difficult for many parents, particularly because of fear about prolonged seizures. Dravet syndrome is not easily diagnosed at this point, but specific, personalized emergency department protocols are needed for children with prolonged febrile seizures to ensure prompt, effective treatment.
During Stage 2, medication efficacy may be marginally better but most negative events are still related to seizures; developmental delay and behavioral problems are of less concern. Parents begin to notice negative effects on their relationships with others. Assistance in locating respite care might be especially valuable to decrease effects on siblings and other family relationships. Psychological or social work intervention might also be useful to avoid these negative effects.
In Stage 3, seizure control is better but cognitive development is disappointing. There may be an actual exacerbation in behavioral problems or, as seizures decrease, behavioral issues are brought to the forefront. Decreased positive and increased negative experiences with the healthcare system may be the result of fewer visits to healthcare professionals. During Stage 3, parents contend with the reality of persistent care for an adult-sized individual, and issues regarding group home placement arise. Parents note a further decline in relationships with others, and coping strategies tend to be more personal/internal. Psychological counselling might help parents maintain relationships or find useful coping mechanisms. In general, however, most parents tend to rate Stage 3 as less stressful than the previous stages.
Second, Dravet syndrome at all stages is dominated by severe seizures. However, other important issues may not receive sufficient attention and yet are major sources of concern for families. Of the children in this sample, 22/24 were reported to have serious cognitive impairment. Neuropsychological testing may help families with this problem. In addition, 22 had sleep problems and 21 had behavioral issues, each of which needs to be addressed individually. This study did not generate specific suggestions for sleep or behaviour problems.
Third, it may be stating the obvious to suggest that healthcare professionals listen carefully to parents. Participants reported many stressful situations when their specific health concerns were ignored, possibly resulting in inadequate care for their children. Treatment protocols that take into account the family's insights may be important.
Our study has limitations. Inclusion was based on clinical diagnosis without mutational analyses. Gene testing is a recent development and will probably become useful for confirmation of the diagnosis; however, only 80% of patients with Dravet syndrome actually demonstrate an SCN1A mutation (Ohmori et al. 2002) so clinical diagnosis remains valuable. Next, we did not specifically ask parents about their fears of death for their child, nor did they spontaneously report such fears. The mortality rate in Dravet Syndrome is 10 to 15% (Dravet et al. 2002) with age of death ranging from 3 to 27 years; the cause of death is typically status epilepticus or related to accidents, but not sudden unexpected death in epilepsy. We are uncertain how best to help families deal with this reality. The small sample size, lack of a comparison/control group, and use of a North American convenience sample that may have emphasized more severe cases are also disadvantages for this study. Fortunately, our participants reported similar experiences across regional and national boundaries. Redundancy of response was noted early in data collection, indicating that an increased sample size may not have been necessary. Finally, our questionnaire was subject to recall bias. The ICND is a more objective measure (Sherman et al. 2002) and the parallel of this instrument with the clinical interview is reassuring.
In conclusion, patients with Dravet syndrome require lifelong care. Parental experiences evolve from terrible anxiety about the diagnosis to extreme stress over constant seizures that do not respond to medication. Eventually they become resigned to a life with restricted social contact but find more personal contentment. Until an effective medical treatment is available, our study points to specific areas where the healthcare system may be able to help families cope more successfully with Dravet syndrome.
DOI: 10.1017/S0012162206001629
Accepted for publication 23rd February 2006. 
